Literature DB >> 19021052

Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States.

Abeer N Abouyabis1, Pareen J Shenoy, Mary Jo Lechowicz, Christopher R Flowers.   

Abstract

Peripheral T-cell lymphomas (PTCL) represent a small subgroup of non-Hodgkin lymphomas historically difficult to diagnose. We conducted a comprehensive assessment of 3287 PTCL cases diagnosed from 1992 to 2005 in 13 Surveillance, Epidemiology and End Results registries. Incidence trends, age-adjusted incidence rates and relative survival rates were compared across the study period, and by sex, race and age groups. From 1992 to 2005, PTCL incidence increased by 280%. Age-adjusted incidence rates were higher in males (Male/Female incidence rate ratio (IRR) 1.8) and in Blacks (Black/White IRR 1.2). Asian predominance was pronounced for extranodal NK/T-cell lymphoma, nasal type. Whites had higher 5-year survival than other racial groups for most histologic subtypes; however, the differences were not statistically significant. The variance in incidence rates and outcomes across PTCL subtypes support the pursuit of ongoing research to identify the etiology, pathophysiology, treatment patterns and differences in treatment response for PTCL subsets.

Entities:  

Mesh:

Year:  2008        PMID: 19021052     DOI: 10.1080/10428190802455867

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  44 in total

1.  New Challenges in the Management of Diffuse Large B-Cell Lymphoma.

Authors:  Christopher R Flowers; Loretta J Nastoupil; Leon Bernal-Mizrachi; Adam C Rose; Rajni Sinha
Journal:  Treat Strategies Hematol       Date:  2012-01

2.  Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project.

Authors:  Anamarija M Perry; Jacques Diebold; Bharat N Nathwani; Kenneth A MacLennan; Hans K Müller-Hermelink; Martin Bast; Eugene Boilesen; James O Armitage; Dennis D Weisenburger
Journal:  Haematologica       Date:  2016-06-27       Impact factor: 9.941

Review 3.  T-cell lymphoma with von Hippel-Lindau disease: a rare case report and review of literature.

Authors:  Li-Hong Lou; Hua Shen; Jun Lin; Yi-Wen Yan; Yan Peng; Jian-Hong Lu; Qu Xu; Hai-Qiong Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 4.  Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.

Authors:  Bradley M Haverkos; Zenggang Pan; Alejandro A Gru; Aharon G Freud; Rachel Rabinovitch; Meng Xu-Welliver; Brad Otto; Carlos Barrionuevo; Robert A Baiocchi; Rosemary Rochford; Pierluigi Porcu
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

5.  Evolving Therapy of Peripheral T-cell Lymphoma: 2010 and beyond.

Authors:  Francine Foss
Journal:  Ther Adv Hematol       Date:  2011-06

6.  A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma.

Authors:  Jennifer E Amengual; Renee Lichtenstein; Jennifer Lue; Ahmed Sawas; Changchun Deng; Emily Lichtenstein; Karen Khan; Laine Atkins; Aishling Rada; Hye A Kim; Codruta Chiuzan; Matko Kalac; Enrica Marchi; Lorenzo Falchi; Mark A Francescone; Lawrence Schwartz; Serge Cremers; Owen A O'Connor
Journal:  Blood       Date:  2017-11-15       Impact factor: 22.113

7.  Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy Outcomes.

Authors:  Jonathan E Brammer; Dai Chihara; L Michelle Poon; Paolo Caimi; Marcos de Lima; Celina Ledesma; Gabriela Rondon; Stefan O Ciurea; Yago Nieto; Michelle Fanale; Bouthaina Dabaja; Richard T Maziarz; Richard E Champlin; Chitra Hosing; Yasuhiro Oki
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2017-10-12

8.  Treatment Strategies for Patients with Diffuse Large B-Cell Lymphoma: Past, Present, and Future.

Authors:  Rajni Sinha; Loretta Nastoupil; Christopher R Flowers
Journal:  Blood Lymphat Cancer       Date:  2012-04-19

Review 9.  Next-generation prognostic assessment for diffuse large B-cell lymphoma.

Authors:  Ashley D Staton; Jean L Koff; Qiushi Chen; Turgay Ayer; Christopher R Flowers
Journal:  Future Oncol       Date:  2015-08-20       Impact factor: 3.404

10.  Development of the Lymphoma Enterprise Architecture Database: a caBIG Silver level compliant system.

Authors:  Taoying Huang; Pareen J Shenoy; Rajni Sinha; Michael Graiser; Kevin W Bumpers; Christopher R Flowers
Journal:  Cancer Inform       Date:  2009-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.